Which begs the question, what is going on with the S1? The SEC is working apparently if they are going after companies making statements that might be untrue.

So, why is there such a big delay on the S1 for Generex? All that was to occur was the added shared in the dividend and then approval is what I thought.

Generex needs to provide information on this, now...